diltiazem has been researched along with pancuronium in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (42.86) | 18.7374 |
| 1990's | 1 (14.29) | 18.2507 |
| 2000's | 2 (28.57) | 29.6817 |
| 2010's | 1 (14.29) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Ahlin, G; Artursson, P; Bergström, CA; Gustavsson, L; Karlsson, J; Larsson, R; Matsson, P; Norinder, U; Pedersen, JM | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Baeyens, JM; Carlos, R; Del Pozo, E; Ocaña, M | 1 |
| Ilias, W; Steinbereithner, K | 1 |
| Hashimoto, Y; Irimada, T; Iwatsuki, N; Koga, Y; Teshigawara, T | 1 |
| Baeyens, JM; Carlos, R; del Pozo, E; Salvador, A | 1 |
1 review(s) available for diltiazem and pancuronium
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
6 other study(ies) available for diltiazem and pancuronium
| Article | Year |
|---|---|
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Structural requirements for drug inhibition of the liver specific human organic cation transport protein 1.
Topics: Cell Line; Computer Simulation; Drug Design; Gene Expression Profiling; Humans; Hydrogen Bonding; Liver; Molecular Weight; Organic Cation Transporter 1; Pharmaceutical Preparations; Predictive Value of Tests; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Structure-Activity Relationship | 2008 |
Differential potentiation by calcium antagonists of neuromuscular blockade induced by pancuronium and succinylcholine in cats in vivo.
Topics: Animals; Calcium Channel Blockers; Cats; Diltiazem; Dose-Response Relationship, Drug; Drug Synergism; Female; Male; Neuromuscular Blocking Agents; Nicardipine; Pancuronium; Stereoisomerism; Succinylcholine; Verapamil | 1992 |
Potentiation of pancuronium induced neuromuscular blockade by calcium channel blockers in vitro.
Topics: Animals; Calcium Channel Blockers; Depression, Chemical; Diltiazem; Drug Synergism; Gallopamil; Male; Neuromuscular Junction; Nifedipine; Nisoldipine; Pancuronium; Rats; Rats, Inbred Strains; Synaptic Transmission; Verapamil | 1985 |
[Diltiazem potentiation of neuromuscular blockage produced by pancuronium or succinylcholine].
Topics: Animals; Diltiazem; Drug Synergism; In Vitro Techniques; Neuromuscular Junction; Pancuronium; Rabbits; Succinylcholine; Synaptic Transmission | 1986 |
Differential effects of calcium channel blocking agents on pancuronium- and suxamethonium-induced neuromuscular blockade.
Topics: Animals; Calcium Channel Blockers; Diltiazem; Drug Synergism; Female; In Vitro Techniques; Muscle Contraction; Neuromuscular Junction; Nicardipine; Pancuronium; Rats; Rats, Inbred Strains; Succinylcholine; Verapamil | 1988 |